TLDR PRP and microneedling are generally safe but can cause rare severe complications.
Platelet-rich plasma (PRP) and microneedling were generally well-tolerated procedures with low rates of adverse events, though some severe complications were reported. PRP was used for facial rejuvenation, wound healing, and alopecia treatment, with mild side effects like transient pain, erythema, and bruising. Rare severe complications included systemic allergic reactions and irreversible blindness from periocular injections. Microneedling, used for acne, scars, and alopecia, had side effects such as erythema, pain, and bleeding, with less common issues like lymphadenopathy and acne flare-ups. Complications could often be avoided with proper patient selection, technique, and adherence to clinical practices.
3 citations
,
August 2019 in “Journal of The American Academy of Dermatology” PRP with microneedling is generally safe but can cause minor side effects like scalp itching, temporary hair shedding, and swollen lymph nodes.
18 citations
,
August 2018 in “Facial Plastic Surgery Clinics of North America” Lasers, microneedling, and PRP improve skin rejuvenation and repair, with PRP enhancing the effects when combined with other treatments.
23 citations
,
June 2018 in “Facial Plastic Surgery” Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.
57 citations
,
May 2016 in “Journal of Dermatological Treatment” PRP therapy may effectively treat hair loss, but more research needed.
66 citations
,
June 2015 in “Aesthetic Plastic Surgery” Platelet preparations generally show positive effects on wound healing and facial rejuvenation, but more thorough research is needed to confirm their effectiveness.
24 citations
,
November 2017 in “Aesthetic Plastic Surgery” All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.